Miami-based Omni Health (OTC:OMHE), a healthcare company developing cannabis-based pharmaceuticals and anti-aging products, announced plans last February 2018 to open a clinic in Miami by December 2018 focused on anti-aging and aesthetic treatments. However, no news has followed, leaving investors with no idea if progress is underway.
The company has 1.14 billion shares outstanding and a stock price currently at US$ 0.004.
Omni said last February that it would lease its first facility in South Miami. The facility would offer anti-aging regenerative medicine solutions. The following were among treatments to be available:
- Bioidentical hormone therapy
- Medical weight loss management
- Nutrient supplements
- I.V. Nutritional Therapy
- Wellness coaching
- Therapies for insomnia, migraines, and stress
- Stem Cell Regeneration Treatments
The market research firm Global Industry Analysts estimated that a baby boomer-fueled consumer base “seeking to keep the dreaded signs of aging at bay” will push the US market for anti-aging products from $80 billion now to more than $114 billion by 2020.
Omni Health claimed last February that it plans to open the new facility in December 2018 with the goal of opening a network of clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Omni further claimed that it anticipates pro-forma annual revenue of $7,500,000 per clinic.
With no news from Omni, it is not surprising that the company’s stock price has steadily drifted down over the year.
Source Omni press release Feb 28, 2018